RE: The ethical reason to release a drug that will save lives09 Feb 2022 23:13
It is a good question - big pharma rushed out their therapies with less data and landed nice contracts with governments. To be honest, I wish SNG mgt would have partnered with big pharma…this would have been rolled out sooner.
How does one distinguish between a deramper from an honest investor who merely wants to play devils advocate to stress test his or her bull thesis? How does one distinguish a pump and dump artist from an honest investor?
Instead or dwelling on a witch hunt, why not be a sponge of all information and decide for oneself or through open discussion?
As for GameStop, that is way overvalued and different dynamics than SNG, which has a legitimate bull case, ie it was a short squeeze.
Very skeptical about the rumors of the new buyer being Maverick. It just isn't their modus operandi. It would be wonderful though, as they have a reputation for seeing quality in mgt and value in certain businesses.
Hi Nick, there are 3 things the management should be communicating to investors: 1. update on SkinBiotix - this has progressed enough for one to expect some forecast on revenue 2. update on AxisBiotix-Ps - At the minimum, I would expect commentary on "clicks" to the adverts 3. cash burn - I would expect some comment on any increase spend directed to their investigation on acne or other ailments. With £4.6m, and cash burn of approx £1.5m pa, that does not leave much time before another dilution event.
Flipping through the RNS, it lacks anything concrete, i.e. figures - not a single mention from mgt of either anticipated revenue or their approach to expense mgt. This vagueness is not enough to support the £85m market cap seen a few days ago and the price is collapsing accordingly.